Overview

Gender

female

Sharon Benzeno is a Chief Business Development Officer. Dr. Benzeno has 15 years of biopharmaceutical experience in oncology, therapeutics, R&D and M&A. Prior to joining Adaptive, Dr. Benzeno worked at AstraZeneca/MedImmune, co-led Capgemini's oncology consulting practice and managed Union Bancaire Privee's biopharmaceutical investment portfolio. Dr. Benzeno has a BA, Magna Cum Laude, in Biochemistry from New York University where she was Phi Beta Kappa. She went on to earn a PhD in Biomedical Sciences from New York University School of Medicine and an MBA in Finance from New York University Stern School of Business. Dr. Benzeno completed her postdoctoral fellowship in cancer biology at the Abramson Cancer Center of the University of Pennsylvania.